封面
市场调查报告书
商品编码
1550592

脱钙骨基质市场:依产品类型、依组织来源、依应用、依最终使用者、按地区

Demineralized Bone Matrix Market, By Product Type, By Tissue Source, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球脱矿骨基质(DBM)市场规模为14.1亿美元,2024年至2031年复合年增长率为6.2%,预计2031年将达21.5亿美元。

报告范围 报告详情
基准年 2023年 2024年市场规模 14.1亿美元
实际资料 2019年至2023年 预测期 从2024年到2031年
预测 2024-2031 年复合年增长率: 6.20% 2031年价值预测 21.5亿美元
图:2024 年按地区分類的脱矿骨基质市场份额 (%)
去矿骨基质市场-IMG1

全球脱矿骨基质市场在过去几年中一直稳定成长。脱矿骨基质(DBM)是由同种异体骨去除骨骼中的矿物质成分后所製成的骨生物材料。由于它促进骨形成,因此在牙科和整形外科手术中用作骨移植的替代品。由于创伤、骨折和各种骨骼相关疾病发生率的增加,牙科和整形外科手术数量不断增加,这是推动全球脱矿骨基质需求的因素之一。此外,人们越来越认识到 DBM 相对于自体骨移植的优势,例如降低供体部位发病率和易于获得,进一步推动了市场的成长。然而,移植骨替代物核准的严格规定可能会在一定程度上抑制市场。

(市场动态):。

推动全球脱矿骨基质市场成长的主要因素包括越来越多的老年人口更容易患骨疾病、牙科疾病盛行率的增加、脊椎融合手术和重组手术数量的增加,其中包括DBM 与骨移植相比的优势。此外,专注于透过各种技术增强 DBM 骨诱导特性的持续研究和开发也为市场参与者创造了新的机会。然而,移植骨替代物核准的严格法律规范以及与 DBM 产品相关的高成本是阻碍市场成长的主要挑战。此外,对合成骨移植等替代骨移植材料的偏好也在一定程度上限制了市场的扩张。

(本次调查的主要特点)

该研究报告对全球脱矿骨基质市场进行了深入分析,包括以2023年为基准年的预测期(2024-2031年)的市场规模(十亿美元)和復合年增长率(CAGR%)。 。

它揭示了各个细分市场的潜在商机,并解释了该市场中有吸引力的投资提案的矩阵。

它还涵盖市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、美敦力、莱特医疗集团、史赛克、强生 (DePuy Synthes)、Zimmer Biomet、Xtant Medical、Hans Biomed 等。对世界主要企业所采取的竞争策略的主要考察。

该报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球脱矿骨基质市场的各种策略矩阵,将促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章全球脱矿骨基质市场,依产品类型,2024-2031

  • 油灰
  • 凝胶
  • 贴上
  • 带材/片材
  • 其他(插头、光纤等)

第五章全球脱钙骨基质市场(依组织来源),2024-2031 年

  • 同种异体移植
  • 异种移植

第六章全球脱矿骨基质市场,依应用分类,2024-2031

  • 脊椎融合手术
  • 创伤
  • 脚和脚踝
  • 牙科
  • 其他用途

第 7 章 全球脱矿骨基质市场,依最终使用者划分,2024-2031 年

  • 医院
  • 整形外科诊所
  • 学术研究所
  • 门诊手术中心
  • 其他的

第8章2019-2031年全球脱矿骨基质市场(按地区)

  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章 竞争格局

  • Medtronic plc
  • Johnson & Johnson(DePuy Synthes)
  • Zimmer Biomet
  • Stryker
  • SeaSpine
  • Xtant Medical
  • RTI Surgical
  • HansBioMed
  • Arthrex GmbH
  • Exactech, Inc.
  • AlloSource
  • Halma(Novabone)
  • Institut Straumann AG
  • Orthofix Holdings, Inc.
  • Straumann
  • Synthes
  • Integra LifeSciences
  • Musculoskeletal Transplant Foundation(MTF)
  • Bacterin International
  • Osiris Therapeutics

第10章分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI4550

The Global Demineralized Bone Matrix Market is estimated to be valued at USD 1.41 Billion in 2024 and is expected to reach USD 2.15 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 1.41 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 6.20% 2031 Value Projection: US$ 2.15 Bn
Figure. Demineralized Bone Matrix Market Share (%), By Region 2024
Demineralized Bone Matrix Market - IMG1

The global demineralized bone matrix market has been growing steadily over the past few years. Demineralized bone matrix (DBM) is an osteobiologic material made from allogeneic bone after removing mineral components from the bone. It is utilized as a bone graft substitute in dental and orthopaedic procedures to stimulate bone formation. Rising number of dental surgeries and orthopaedic procedures due to increasing incidence of trauma injuries, bone fractures and various bone related diseases are some of the factors fueling demand for demineralized bone matrix globally. Moreover, growing awareness about advantages of DBM over autografts such as reduced donor site morbidity and greater availability is further supplementing the market growth. However, stringent regulations for approval of bone graft substitutes may restrain the market to a certain extent.

(Market Dynamics):

The key drivers propelling the growth of the global demineralized bone matrix market include rising geriatric population susceptible to bone disorders, increasing prevalence of dental diseases, growing number of spinal fusion and reconstruction surgeries, and advantages offered by DBM over conventional bone grafts. Additionally, ongoing research and development activities focused on enhancing osteoinductive properties of DBM through various techniques are creating new opportunities for market players. However, stringent regulatory framework for approval of bone graft substitutes and high costs associated with DBM products are some of the major challenges hampering the market growth. Moreover, preference for alternative bone grafting materials such as synthetic bone grafts is also restricting the market expansion to some extent.

(Key features of the study):

This report provides in-depth analysis of the global demineralized bone matrix market, and provides market size (USD billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players such as Medtronic, Wright Medical Group, Stryker, J &J (DePuy Synthes), Zimmer Biomet, Xtant Medical, and Hans Biomed

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global demineralized bone matrix market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global demineralized bone matrix market.

Detailed Segmentation:

  • Product Type Insights (Revenue, USD Bn, 2019 - 2031)
    • Putty
    • Gel
    • Paste
    • Strips/Sheets
    • Others (Plugs, Fibers, etc.)
  • Tissue Source Insights (Revenue, USD Bn, 2019 - 2031)
    • Allograft
    • Xenograft
  • Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Spinal Fusion
    • Trauma
    • Foot and Ankle
    • Dental
    • Other Applications
  • End user Insights (Revenue, USD Bn, 2019 - 2031)
    • Hospitals
    • Orthopedic Clinics
    • Academic and Research Institutes
    • Ambulatory Surgical Centers
    • Others
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Medtronic plc
    • Johnson & Johnson (DePuy Synthes)
    • Zimmer Biomet
    • Stryker
    • SeaSpine
    • Xtant Medical
    • RTI Surgical
    • HansBioMed
    • Arthrex GmbH
    • Exactech, Inc.
    • AlloSource
    • Halma (Novabone)
    • Institut Straumann AG
    • Orthofix Holdings, Inc.
    • Straumann
    • Synthes
    • Integra LifeSciences
    • Musculoskeletal Transplant Foundation (MTF)
    • Bacterin International
    • Osiris Therapeutics

Table of Contents

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

  • Research Objectives
  • Assumptions
  • Abbreviations

2. MARKET PURVIEW

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Demineralized Bone Matrix Market, By Product Type
    • Global Demineralized Bone Matrix Market, By Tissue Source
    • Global Demineralized Bone Matrix Market, By Application
    • Global Demineralized Bone Matrix Market, By End User
    • Global Demineralized Bone Matrix Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Demineralized Bone Matrix Market, By Product Type, 2024-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Putty
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Gel
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Paste
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Strips/Sheets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others (Plugs, Fibers, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Demineralized Bone Matrix Market, By Tissue Source, 2024-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Allograft
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Xenograft
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Demineralized Bone Matrix Market, By Application, 2024-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Spinal Fusion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Trauma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Foot and Ankle
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Demineralized Bone Matrix Market, By End-User, 2024-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Orthopedic Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Demineralized Bone Matrix Market, By Region, 2019 - 2031, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
  • South Africa
  • North Africa
  • Central Africa

9. COMPETITIVE LANDSCAPE

  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson (DePuy Synthes)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zimmer Biomet
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SeaSpine
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Xtant Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • RTI Surgical
  • HansBioMed
  • Arthrex GmbH
  • Exactech, Inc.
  • AlloSource
  • Halma (Novabone)
  • Institut Straumann AG
  • Orthofix Holdings, Inc.
  • Straumann
  • Synthes
  • Integra LifeSciences
  • Musculoskeletal Transplant Foundation (MTF)
  • Bacterin International
  • Osiris Therapeutics

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us